ERR4976617
— · D
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- D
- subtype
- D
- overall_survival_months
- 112
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- INTERFERON_ALPHA_RESPONSE+0.600
- INTERFERON_GAMMA_RESPONSE+0.500
- ALLOGRAFT_REJECTION+0.490
- IL6_JAK_STAT3_SIGNALING+0.410
- COMPLEMENT+0.130
- PANCREAS_BETA_CELLS+0.090
- PI3K_AKT_MTOR_SIGNALING+0.080
- INFLAMMATORY_RESPONSE+0.050
- WNT_BETA_CATENIN_SIGNALING+0.050
- HEME_METABOLISM+0.040
Top 10 suppressed
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.540
- ESTROGEN_RESPONSE_EARLY-0.490
- ESTROGEN_RESPONSE_LATE-0.490
- ANGIOGENESIS-0.480
- CHOLESTEROL_HOMEOSTASIS-0.480
- MTORC1_SIGNALING-0.410
- GLYCOLYSIS-0.400
- HEDGEHOG_SIGNALING-0.370
- OXIDATIVE_PHOSPHORYLATION-0.330
- E2F_TARGETS-0.320
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | ERR4976618 | — | D | 0.943 |
| 2 | MBCProject_1819_T2B_RNA | — | D | 0.905 |
| 3 | ERR2208899 | — | — | 0.895 |
| 4 | AUR-AG0J-TTP1-A-1-0-R-A741-41 | — | D | 0.891 |
| 5 | SRR8518305 | — | D | 0.877 |
| 6 | be8d8236-4ebc-46de-a4fd-a901fec1cdce | — | — | 0.870 |
| 7 | TCGA-E9-A2JT-01A-22R-A18M-07 | — | D | 0.869 |
| 8 | TCGA-AO-A0JC-01A-11R-A056-07 | — | D | 0.868 |
| 9 | SRR1313132 | — | D | 0.862 |
| 10 | s0122145 | — | — | 0.848 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 10 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.600 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.500 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.490 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.410 | Inavolisib | — uncovered |
| COMPLEMENT | 0.130 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.090 | Cobimetinib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.080 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.050 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.050 | Inavolisib | — uncovered |
| HEME_METABOLISM | 0.040 | Temsirolimus | — uncovered |